The space of GLP-1 medications has expanded significantly, and understanding your options helps you have an informed conversation with your provider
Initially developed to treat type 2 diabetes, GLP-1 receptor agonists are now widely used for weight loss due to their ability to mimic the hormones natural effects
The Wegovy dose, however, has been specifically formulated for weight loss, so you can expect to achieve better weight loss results with Wegovy
A cost per response analysis evaluating the SGLT-2 inhibitors took a different approach, calculating the cost per 1% reduction in HbA1c with empagliflozin 10 mg or 25 mg (the SGLT-2 inhibitor included in the present analysis), canagliflozin 100 mg and 300 mg, dapagliflozin 5 mg or 10 mg, and in monotherapy, dual therapy with metformin, and triple therapy with metformin and sulfonylurea [25]
Clinical Trial Data: Efficacy and Safety of Tirzepatide and Semaglutide